| Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome (NCT05444946) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2022-06-15 |
| A Prospective Study on Optimizing Treatment for ABPA (NCT05129033) | Shanghai Zhongshan Hospital | 2021-11-15 |
| ML-Based ABPA Recurrence Prediction and Clinical Utility (NCT07714863) | Qianfoshan Hospital | 2021-01-01 |
| Investigating Treatment With Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED) (NCT04442269) | Regeneron Pharmaceuticals | 2020-09-15 |
| Deflazacort Vs. Prednisolone in Acute-stage ABPA (NCT04227483) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2020-01-15 |
| Benralizumab in the Treatment of Patients With Severe Asthma With ABPA (NCT04108962) | Baylor Research Institute | 2019-12-23 |
| Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis (NCT03960606) | Pulmatrix Inc. | 2019-07-31 |
| Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (NCT03059992) | Scynexis, Inc. | 2017-04-01 |
| A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis (NCT02440009) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2014-05-01 |
| Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis (NCT01621321) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2013-06-01 |
| A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis (NCT01857479) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2013-05-01 |
| Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis (NCT01321827) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2011-04-01 |
| Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis (NCT01222273) | University of Pittsburgh | 2010-09-01 |
| Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis (NCT00974766) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2009-04-01 |
| An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) (NCT00787917) | Novartis Pharmaceuticals | 2008-11-01 |
| Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA (NCT00585364) | University of Pittsburgh | 2005-03-01 |
| Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis (NCT05897294) | TFF Pharmaceuticals, Inc. | |